----

----

| þ   | QUARTERLY      REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 |
|--------------------|---------------------------------------------------------------------------------------------|
|               | For      the quarterly period ended  March 31,      2008                          |

| o   | TRANSITION      REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 |
|---------------|----------------------------------------------------------------------------------------------|
|          | For      the transition period from ______________  to________________                       |

----

| Idaho                                                               |   | 04-3413196                                |
|---------------------------------------------------------------------|--------|-------------------------------------------|
| (State      or other jurisdiction of incorporation or organization) |   | (I.R.S.      Employer Identification No.) |

|   | 310 Authority      DriveFitchburg, MA       01420   |  |
|--------|----------------------------------------------------------|--|
|        | (Address      of principal executive offices) (Zip Code) |  |

|   | (978)      696-0020                                         |  |
|--------|-------------------------------------------------------------|--|
|        | (Issuer’s      telephone number, including area code) |  |

| Title of      class                               | Name of Exchange on Which      Registered |
|---------------------------------------------------|-------------------------------------------|
|  Common      Stock, par value $.01 per share |  None                                |

----

----

|                                               | PAGE                                                                    |
|----------------------------------------------------|-------------------------------------------------------------------------|
| PART      II. – FINANCIAL INFORMATION   |                                                                    |
|                                               |                                                                    |   |
| ITEM      1                                        | Financial      Statements                                               | 3 -      12 |
|                                               |                                                                    |   |
| ITEM      2                                        | Plan      of Operation; Management’s Discussion      and Analysis | 13 |
|                                               |                                                                    |   |
| ITEM      3                                        | Controls      and Procedures                                            | 14 |
|                                               |                                                                    |   |
|                                               |                                                                    |   |
|                                               |                                                                    |   |
| PART      II.  – OTHER INFORMATION |                                                                    |
|                                               |                                                                    |   |
| ITEM      1                                        | Legal      Proceedings                                                  | 14 |
|                                               |                                                                    |   |
| ITEM      2                                        | Unregistered      Sales of Equity Securities and Use of Proceeds        | 14 |
|                                               |                                                                    |   |
| ITEM      3                                        | Default      Upon Senior Securities                                     | 15 |
|                                               |                                                                    |   |
| ITEM      4                                        | Submission      of Matters to a Vote of Security Holders                | 15 |
|                                               |                                                                    |   |
| ITEM      5                                        | Other      Information                                                  | 16 |
|                                               |                                                                    |   |
| ITEM      6                                        | Exhibits      and Reports on Form 8-K                                   | 16 |
|                                               |                                                                    |   |
| SIGNATURES                                         |                                                                    | 17 |

----

| 4           | Balance      Sheets As At March 31, 2008 And December 31, 2007                                                                                                    |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|        |                                                                                                                                                              |
| 5           | Statements  Of  Operations  And  Income      For The Three Months  Ended March 31, 2008 and March 31,      2007 |
|        |                                                                                                                                                              |
| 6           | Statements  Of      Cash  Flows For The Three Months  Ended March 31, 2008      and March 31, 2007                                  |
|        |                                                                                                                                                              |
| 7 -      11 | Notes      To Financial Statements – March 31, 2008                                                                                                         |

----

| INTEGRATED      PHARMACEUTICALS, INC. |
|---------------------------------------|
| (A      Development Stage Company)    |
| BALANCE      SHEETS                   |

|                                                    |   | 31-Mar      |         |   | Audited           |    |
|---------------------------------------------------------|--------|-------------|--------------|--------|-------------------|---------|
|                                                    |   | 2008        |         |   | December      31, |    |
|                                                    |   | (unaudited) |         |   | 2007              |    |
|                                                    |   |        |         |   |              |    |
| ASSETS                                                  |   |        |         |   |              |    |
| CURRENT      ASSETS                                     |   |        |         |   |              |    |
| Cash                                                    |   | $      |  90,658 |   |              | $  |  66,503 |   |
| Accounts      receivable                                |   |        | 27,687       |   |              |    | 27,687 |   |
| Inventory                                               |   |        | 107,922      |   |              |    | 107,922 |   |
| Prepaid      expenses                                   |   |        | 22,908       |   |              |    | 43,699 |   |
| Total      Current Assets                               |   |        | 249,175      |   |              |    | 245,811 |   |
|                                                    |   |        |         |   |              |    |   |   |
| PROPERTY      AND EQUIPMENT, net                        |   |        | 620,084      |   |              |    | 754,737 |   |
|                                                    |   |        |         |   |              |    |   |   |
| OTHER      ASSETS                                       |   |        |         |   |              |    |   |   |
| Investments                                             |   |        | 1,940        |   |              |    | 2,390 |   |
| Deposits                                                |   |        | —      |   |              |    |   |   |
| Patents,      net of amortization                       |   |        | 100,645      |   |              |    | 102,123 |   |
| Total      Other Assets                                 |   |        | 102,585      |   |              |    | 104,513 |   |
|                                                    |   |        |         |   |              |    |   |   |
| TOTAL      ASSETS                                       |   | $           | 971,844      |   |              | $       | 1,105,061 |   |
|                                                    |   |        |         |   |              |    |   |   |
| LIABILITIES      AND STOCKHOLDERS' EQUITY               |   |        |         |   |              |    |   |   |
| CURRENT      LIABILITIES                                |   |        |         |   |              |    |   |   |
| Accounts      payable                                   |   | $           | 170,456      |   |              | $       | 155,852 |   |
| Accrued      expenses                                   |   |        | 84,500       |   |              |    | 113,482 |   |
| Related      party short-term debt                      |   |        |         |   |              |    | — |   |
| Capital      leases payable - current portion           |   |        | —      |   |              |    | — |   |
| Total      Current Liabilities                          |   |        | 254,956      |   |              |    | 269,334 |   |
|                                                    |   |        |         |   |              |    |   |   |
|                                                    |   |        |         |   |              |    |   |   |
| COMMITMENTS      AND CONTINGENCIES                      |   |        | —      |   |              |    | — |   |
|                                                    |   |        |         |   |              |    |   |   |
| STOCKHOLDERS'      EQUITY                               |   |        |         |   |              |    |   |   |
| Preferred      stock, $0.10 par value, 20,000 shares    |   |        |         |   |              |    |   |   |
| authorized;      no shares issued                       |   |        |         |   |              |    | — |   |
| Common      stock, $0.01 par value, 75,000,000 shares   |   |        |         |   |              |    |   |   |
|  authorized;      22,553,106 and 18,632,626 shares |   |        |         |   |              |    |   |   |
| issued      and outstanding, respectively               |   |        | 436,103      |   |              |    | 422,449 |   |
| Additional      paid-in capital                         |   |        | 17,548,096   |   |              |    | 17,290,290 |   |
| Other      comprehensive income (loss)                  |   |        | (80          | )      |              |    | 370 |   |
| Accumulated      deficit prior to development stage     |   |        | (494,624     | )      |              |    | (494,624 | ) |
| Accumulated      deficit during development stage       |   |        | (16,772,607  | )      |              |    | (16,382,758 | ) |
|                                                    |   |        |         |   |              |    |   |   |
| Total      Stockholders' Equity                         |   |        | 716,888      |   |              |    | 835,727 |   |
|                                                    |   |        |         |   |              |    |   |   |
| TOTAL      LIABILITIES AND                              |   |        |         |   |              |    |   |   |
| STOCKHOLDERS'      EQUITY                               |   | $           | 971,844      |   |              | $       | 1,105,061 |   |

----

| INTEGRATED      PHARMACEUTICALS, INC. |
|---------------------------------------|
| (A      Development Stage Company)    |
| STATEMENTS      OF OPERATIONS         |

|                                           |   |                         |       |   |                |   |       | Period      from        |   |
|------------------------------------------------|--------|------------------------------|------------|--------|---------------------|--------|------------|-------------------------|--------|
|                                           |   |                         |       |   |                |   |       | February      1, 2003   |   |
|                                           |   | Three Months      Ended |       |   | (inception      of  |   |
|                                           |   |                         |       |   |                |   |       | development      stage) |   |
|                                           |   | March      31, 2008          |       |   | March      31, 2007 |   |       | to      March 31,2008   |   |
|                                           |   | (unaudited)                  |       |   | (unaudited)         |   |       | (unaudited)             |   |
|                                           |   |                         |       |   |                |   |       |                    |   |
| REVENUES                                       |   | $                            | —    |   |                | $      | —    |                    |   | $ | 173,399 |   |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| COST      OF GOODS SOLD                        |   |                         |       |   |                |   |       |                    |   |   |   |   |
| Materials      and supplies                    |   |                         | —    |   |                |   | —    |                    |   |   | 113,484 |   |
| Total      Cost of Goods Sold                  |   |                         | —    |   |                |   | —    |                    |   |   | 113,484 |   |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| GROSS      PROFIT                              |   |                         | —    |   |                |   | —    |                    |   |   | 59,915 |   |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| GENERAL      AND ADMINISTRATIVE EXPENSES       |   |                         |       |   |                |   |       |                    |   |   |   |   |
| Depreciation      and amortization             |   |                         | 65,706     |   |                |   | 65,844     |                    |   |   | 981,397 |   |
| Research      and development                  |   |                         | 48,409     |   |                |   | 55,558     |                    |   |   | 1,126,480 |   |
| Marketing                                      |   |                         | 2,025      |   |                |   | 355        |                    |   |   | 641,428 |   |
| Legal      and professional fees               |   |                         | 23,381     |   |                |   | 79,525     |                    |   |   | 1,442,723 |   |
| Consulting                                     |   |                         |       |   |                |   | 59,359     |                    |   |   | 3,193,448 |   |
| Idle      facility expense                     |   |                         | 119,370    |   |                |   | 139,884    |                    |   |   | 2,453,457 |   |
| Occupancy                                      |   |                         | 52,416     |   |                |   | 30,985     |                    |   |   | 1,215,390 |   |
| Labor      and benefits                        |   |                         | 31,831     |   |                |   | 22,575     |                    |   |   | 919,259 |   |
| Services      paid by stock options            |   |                         | 2,850      |   |                |   | 2,850      |                    |   |   | 1,494,423 |   |
| Office      supplies and expenses              |   |                         | 4,059      |   |                |   | 7,255      |                    |   |   | 201,422 |   |
| Travel                                         |   |                         | 1,315      |   |                |   | 770        |                    |   |   | 185,704 |   |
| Other      general and administrative expenses |   |                         | 37,053     |   |                |   | 29,167     |                    |   |   | 671,052 |   |
| Total      General and Administrative Expenses |   |                         | 388,415    |   |                |   | 494,127    |                    |   |   | 14,526,183 |   |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| OPERATING      INCOME (LOSS)                   |   |                         | (388,415   | )      |                |   | (494,127   | )                       |   |   | (14,466,268 | ) |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| OTHER      INCOME (EXPENSES)                   |   |                         |       |   |                |   |       |                    |   |   |   |   |
| Interest      income                           |   |                         | 2          |   |                |   | 2          |                    |   |   | 10,285 |   |
| Interest      expense                          |   |                         | (1,436     | )      |                |   | (1,901     | )                       |   |   | (1,433,645 | ) |
| Other      income (expense)                    |   |                         | —    |   |                |   | —    |                    |   |   | (5,560 | ) |
| Total      Other Income and Expenses           |   |                         | (1,434     | )      |                |   | (1,899     | )                       |   |   | (1,428,920 | ) |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| LOSS      BEFORE TAXES                         |   |                         | (389,849   | )      |                |   | (496,026   | )                       |   |   | (15,895,188 | ) |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| INCOME      TAXES                              |   |                         | —    |   |                |   | —    |                    |   |   | — |   |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| NET      LOSS                                  |   |                         | (389,849   | )      |                |   | (496,026   | )                       |   |   | (15,895,188 | ) |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| OTHER      COMPREHENSIVE INCOME (LOSS)         |   |                         |       |   |                |   |       |                    |   |   |   |   |
| Unrealized      gain (loss) in market value of |   |                         |       |   |                |   |       |                    |   |   |   |   |
| investments                                    |   |                         | (80        | )      |                |   | (870       | )                       |   |   | 1,570 |   |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| COMPREHENSIVE      LOSS                        |   | $                            | (389,929   | )      |                | $      | (496,896   | )                       |   | $ | (15,893,618 | ) |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| NET      INCOME (LOSS) PER COMMON SHARE,       |   |                         |       |   |                |   |       |                    |   |   |   |   |
| BASIC      AND DILUTED                         |   | $                            | (0.01      | )      |                | $      | (0.01      | )                       |   |   |   |   |
|                                           |   |                         |       |   |                |   |       |                    |   |   |   |   |
| WEIGHTED      AVERAGE NUMBER OF COMMON         |   |                         |       |   |                |   |       |                    |   |   |   |   |
| SHARES      OUTSTANDING, BASIC AND DILUTED     |   |                         | 43,870,839 |   |                |   | 40,523,130 |                    |   |   |   |   |

----

| INTEGRATED      PHARMACEUTICALS, INC. |
|---------------------------------------|
| (A      Development Stage Company)    |
| STATEMENTS      OF CASH FLOWS         |

|                                                                 |   |                |                 |   |                |   |     | Period      from        |   |
|----------------------------------------------------------------------|--------|---------------------|----------------------|--------|---------------------|--------|----------|-------------------------|--------|
|                                                                 |   |                |                 |   |                |   |     | February      1, 2003   |   |
|                                                                 |   |                |                 |   |                |   |     | (inception      of      |   |
|                                                                 |   | Period      Ended   |                 |   | Period      Ended   |   |     | development      stage) |   |
|                                                                 |   | March      31, 2008 |                 |   | March      31, 2007 |   |     | to      March 31, 2008  |   |
| CASH      FLOWS FROM OPERATING ACTIVITIES:                           |   |                |                 |   |                |   |     |                    |   |
| Net      income (loss)                                               |   | $                   | (389,849             | )      |                | $      | (496,026 | )                       |   | $ | (16,743,797 | ) |
| Adjustments      to reconcile net income (loss) to net cash          |   |                | ——  |   |                |   |     |                    |   |   |   |   |
|   flows      provided (used) by operating activities:      |   |                |                 |   |                |   |     |                    |   |   |   |   |
| Depreciation      and amortization                                   |   |                | 134,653              |   |                |   | 137,988  |                    |   |   | 2,020,957 |   |
| Loss      on disposition of assets                                   |   |                | —              |   |                |   | —  |                    |   |   | 7,024 |   |
| Stock      and warrants issued as incentive for notes payables       |   |                | —              |   |                |   | —  |                    |   |   | 496,389 |   |
| Stock      issued for interest expense                               |   |                | —              |   |                |   | —  |                    |   |   | 149,878 |   |
| Stock      issued for rent expense                                   |   |                | 998                  |   |                |   | 7,298    |                    |   |   | 616,577 |   |
| Stock      issued for services                                       |   |                | 2,612                |   |                |   | 21,221   |                    |   |   | 1,212,124 |   |
| Stock      issued for assets and securities                          |   |                | —              |   |                |   | —  |                    |   |   | 43,739 |   |
| Stock      options and warrants vested                               |   |                | 2,850                |   |                |   | 62,209   |                    |   |   | 3,968,408 |   |
| Recognition      of noncash deferred financing expense               |   |                | —              |   |                |   | —  |                    |   |   | 578,699 |   |
| Options      and warrants issued for services and financing          |   |                | —              |   |                |   | —  |                    |   |   | 253,753 |   |
| Other      Adjustments                                               |   |                | —              |   |                |   | —  |                    |   |   | (1,850 | ) |
| Changes      in assets and liabilities:                              |   |                |                 |   |                |   |     |                    |   |   |   |   |
| Receivables                                                          |   |                | —              |   |                |   | —  |                    |   |   | (11,603 | ) |
| Inventory                                                            |   |                | —              |   |                |   | (1,641   | )                       |   |   | (107,922 | ) |
| Prepaid      expenses                                                |   |                | 20,791               |   |                |   | 32,169   |                    |   |   | 117,794 |   |
| Other      assets                                                    |   |                | —              |   |                |   | —  |                    |   |   | 13,247 |   |
| Accounts      payable                                                |   |                | 14,604               |   |                |   | (98,623  | )                       |   |   | 71,716 |   |
| Accrued      expenses                                                |   |                | (28,982              | )      |                |   | (37,435  | )                       |   |   | (98,483 | ) |
| Net      cash used by operating activities                           |   |                | (242,323             | )      |                |   | (372,840 | )                       |   |   | (7,413,350 | ) |
|                                                                 |   |                |                 |   |                |   |     |                    |   |   |   |   |
| CASH      FLOWS FROM INVESTING ACTIVITIES:                           |   |                |                 |   |                |   |     |                    |   |   |   |   |
| Purchase      of fixed assets                                        |   |                | —              |   |                |   | —  |                    |   |   | (2,761,533 | ) |
| Patent      costs                                                    |   |                | 1,478                |   |                |   | (2,815   | )                       |   |   | (115,267 | ) |
| Leasehold      concessions received                                  |   |                | —              |   |                |   | —  |                    |   |   | 185,000 |   |
| Net      cash used by investing activities                           |   |                | 1,478                |   |                |   | (2,815   | )                       |   |   | (2,691,800 | ) |
|                                                                 |   |                |                 |   |                |   |     |                    |   |   |   |   |
| CASH      FLOWS FROM FINANCING ACTIVITIES:                           |   |                |                 |   |                |   |     |                    |   |   |   |   |
| Sale      of common stock units                                      |   |                | 265,000              |   |                |   | 24,500   |                    |   |   | 9,033,140 |   |
| Payments      on capital leases                                      |   |                | —              |   |                |   | —  |                    |   |   | (9,563 | ) |
| Proceeds      from related party loans                               |   |                | —              |   |                |   | (11,339  | )                       |   |   | (56,701 | ) |
| Proceeds      from exercise of options                               |   |                | —              |   |                |   | —  |                    |   |   | 1,080 |   |
| Proceeds      from convertible debt                                  |   |                | —              |   |                |   | —  |                    |   |   | 939,900 |   |
| Net      cash provided by financing activities                       |   |                | 265,000              |   |                |   | 13,161   |                    |   |   | 9,907,856 |   |
|                                                                 |   |                |                 |   |                |   |     |                    |   |   |   |   |
| Net      increase in cash                                            |   |                | 24,155               |   |                |   | (362,494 | )                       |   |   | (197,294 | ) |
|                                                                 |   |                |                 |   |                |   |     |                    |   |   |   |   |
| Cash,      beginning of period                                       |   |                | 66,503               |   |                |   | 872,182  |                    |   |   | 287,952 |   |
|                                                                 |   |                |                 |   |                |   |     |                    |   |   |   |   |
| Cash,      end of period                                             |   | $                   | 90,658               |   |                | $      | 509,688  |                    |   | $ | 90,658 |   |
|                                                                 |   |                | —              |   |                |   |     |                    |   |   |   |   |
|                                                                 |   |                |                 |   |                |   |     |                    |   |   |   |   |
|                                                                 |   |                |                 |   |                |   |     |                    |   |   |   |   |
| SUPPLEMENTAL      CASH FLOW DISCLOSURES:                             |   |                |                 |   |                |   |     |                    |   |   |   |   |
| Income      taxes paid                                               |   | $                   | —              |   |                | $      | —  |                    |   | $ | — |   |
| Interest      paid                                                   |   | $                   | —              |   |                | $      | —  |                    |   | $ | 25,000 |   |
|                                                                 |   |                |                 |   |                |   |     |                    |   |   |   |   |
| NON-CASH      INVESTING AND FINANCING:                               |   |                |                 |   |                |   |     |                    |   |   |   |   |
| Stock      options and warrants vested                               |   | $                   | 2,850                |   |                | $      | —  |                    |   | $ | 3,739,965 |   |
| Stock      and warrants issued for convertible debt                  |   | $                   | —              |   |                | $      | —  |                    |   | $ | 1,613,076 |   |
| Stock      issued for assets and securities                          |   | $                   | —              |   |                | $      | —  |                    |   | $ | 43,739 |   |
| Stock      issued as deferred incentive for notes payables           |   | $                   | —              |   |                | $      | —  |                    |   | $ | 519,587 |   |
| Stock      issued for prepaid and deferred rent and rent expense     |   | $                   | 998                  |   |                | $      | —  |                    |   | $ | 599,762 |   |
| Stock      and warrants issued for services                          |   | $                   | 2,612                |   |                | $      | —  |                    |   | $ | 1,078,701 |   |
| Warrants      and options issued for deferred services and financing |   | $                   | —              |   |                | $      | —  |                    |   | $ | 520,102 |   |
| Accounts      payable paid by contributed capital                    |   | $                   | —              |   |                | $      | —  |                    |   | $ | 27,767 |   |
| Noncash      recovery of other income                                |   | $                   | —              |   |                | $      | —  |                    |   | $ | 1,850 |   |

----

| STATEMENT      OF STOCKHOLDERS' EQUITY |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|----------------------------------------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|
|                                   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |

|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             | Accumulated                                                                                                                                 |    |                                              |                                                                                                                      |
|-------------------------------------------------------|-------------------------------------------------|------------------|---------------------------------------------------------------------------------------------------------------------|---------|---------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|---------|------------------------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------|--------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------|------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|---------|---------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|
|                                                  |                                            |             |  Common      Stock                                                                                             |    |                                              | Additional                                                                                                                |    | Accumulated                  |                                                                                          |                                                                                    | Accumulated                                                                                                                                                         |                   |                                                         | Other                                                                                                                                                               |    |                                                                                                             |                                                                                                                                        |
|                                                  |                                            |             |  Number                                                                                                        |    |                                              |                                                                                                                      |    |                         | Paid-in                                                                                       |                                                                                    | Deficit      Prior to                                                                                                                                               |                   | Deficit      During                                          |                                                                                                                                                                |    | Comprehensive                                                                                                    |                                                                                                                                        |
|                                                  |                                            |             |  of      Shares                                                                                                |    |                                              | Amount                                                                                                                    |    |                         | Capital                                                                                       |                                                                                    | Development      Stage                                                                                                                                              | Development      Stage | Loss                                                         |                                                                                                                                                                |    | Total                                                                                                            |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Balance,      December 31, 2007                       |                                            |  42,505,005 |                                                                                                                |  $ |        422,449 |                                                                                                                      |  $ |    17,290,290 |                                                                                          |              (494,624) |                                                                                                                                                                |  $                |         (16,382,758) |                                                                                                                                                                |  $ |                   370  |                                                                                                                                        |  $ |        835,727 |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Stock      issued at an average of $.12 per      |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |
|                                                  | share      in exchange for legal services  |             | 22,363                                                                                                              |    |                                              | 219                                                                                                                       |    |                         |  2,393                                                                                   |                                                                                    |  —                                                                                                                                                       |                   |                                                         |  —                                                                                                                                                       |    |                                                                                                             |  —                                                                                                                               |    |                                              |  2,612                                                                                                               |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Stock      issued at an average price of              |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |
|                                                  | $.06      per share in exchange                 |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
|                                                  | for      rent expense                           |             |         18,471                                                              |    |                                              |               185                                   |    |                         |                813 |                                                                                    |                           — |                   |                                                         |                           — |    |                                                                                                             |                       — |    |                                              |               998                                   |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Shares      issued to directors for services     |                                            | —          |                                                                                                                |    | —                                           |                                                                                                                      |    | —                      |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    | —                                           |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Value      of warrants vested during the period  |                                            |             |                                                                                                                |    | —                                           |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    | —                                           |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Value      of options vested during the period   |                                            |             |                                                                                                                |    |  —                                     |                                                                                                                      |    |  2,850                  |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |  2,850                                       |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Stock      and warrants issued for private       |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |
|                                                  | placement                                       |             |    1,325,000                                                                                         |    |                                              |          13,250                                                              |    |                         |         251,750                                       |                                                                                    |                           — |                   |                                                         |                           — |    |                                                                                                             |                       — |    |                                              |        265,000                                                                         |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Adjustment      for employee options vested      |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |
|                                                  | but      not exercised                          |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                    — |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Unrealized      gain on market value of          |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |
|                                                  | investment                                      |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                 (450)                                       |    |                                              |              (450)                                       |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Other      Adjustments                                |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Net      loss for the Period ended                    |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |
|                                                  | March      31, 2008                             |             |                   — |    |                                              |                    — |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |              (389,849)                                                                             |    |                                                                                                             |                       — |    |                                              |       (389,849)                                                                             |
|                                                  |                                            |             |                                                                                                                |    |                                              |                                                                                                                      |    |                         |                                                                                          |                                                                                    |                                                                                                                                                                |                   |                                                         |                                                                                                                                                                |    |                                                                                                             |                                                                                                                                        |    |                                              |                                                                                                                      |
| Balance,      March 31, 2007                          |                                            |  43,870,839 |                                                                                                                |  $ |        436,103 |                                                                                                                      |  $ |    17,548,096 |                                                                                          |              (494,624) |                                                                                                                                                                |  $                |         (16,772,607) |                                                                                                                                                                |  $ |                   (80) |                                                                                                                                        |  $ |        716,888 |

----

----

----

----

|   | Level      1 -   | Unadjusted      quoted prices in active markets that are accessible at the measurement      date for identical unrestricted assets or    liabilities.                            |
|--------|----------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                       |                                                                                                                                                                                  |
|   | Level      2 -             | Quoted      prices in markets that are not active, or inputs that are observable,      either directly or indirectly, for substantially the full term of the      asset or liability. |

|   | Level      3 - | Prices      or valuation techniques that require inputs that are both significant to      fair value measurement and unobservable (supported by little or no market      activity). |
|--------|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

|                                           |   | March      31,2008 |       |   | December      31,2007 |   |
|------------------------------------------------|--------|--------------------|------------|--------|-----------------------|--------|
| Equipment                                      |   | $                  | 1,818,250  |   |                  | $      | 1,818,250 |   |
| Furniture      and fixtures                    |   |               | 120,114    |   |                  |   | 120,114 |   |
| Leasehold      improvements                    |   |               | 826,511    |   |                  |   | 826,511 |   |
|                                           |   |               | 2,764,875  |   |                  |   | 2,764,875 |   |
| Less:  Accumulated      depreciation |   |               | (2,144,791 | )      |                  |   | (2,010,137 | ) |
| Total                                          |   | $                  | 620,084    |   |                  | $      | 754,738 |   |

----

----

| Plan                                                           |   | Number      of securities to be issued upon exercise of outstandingoptions |   | Weighted-average      exercise price of outstanding options |   | Number      of securities remaining available for future issuance under equity      compensation plans |
|----------------------------------------------------------------|--------|----------------------------------------------------------------------------|--------|-------------------------------------------------------------|--------|--------------------------------------------------------------------------------------------------------|
|                                                           |   |                                                                       |   |                                                        |   |                                                                                                   |
| Equity      compensation plan approved by security holders (1) |   |  538,888                                                         |   | $0.62                                                       |   |  1,061,112                                                                                   |
|                                                           |   |                                                                       |   |                                                        |   |                                                                                                   |
| Total                                                          |   | 538,888                                                                    |   |                                                        |   | 1,061,112                                                                                              |

|                                                        |   | Number      of Shares |      |   | Weighted      Average Exercise Price |   |
|-------------------------------------------------------------|--------|-----------------------|-----------|--------|--------------------------------------|--------|
| Outstanding      at January 1, 2007                         |   |                  | 1,297,222 |   |                                 | $      | 0.55 |   |
| Granted                                                     |   |                  |      |   |                                 |   |   |   |
| Exercised                                                   |   |                  | —   |   |                                 |   | — |   |
| Rescinded                                                   |   |                  | (475,000  | )      |                                 |   | — |   |
| Outstanding      at December 31, 2007                       |   |                  | 822,222   |   |                                 |   | 0.62 |   |
| Granted                                                     |   |                  | —   |   |                                 |   | — |   |
| Exercised                                                   |   |                  | —   |   |                                 |   | — |   |
| Rescinded/Expired                                           |   |                  | (283,333  | )      |                                 |   | — |   |
| Options      outstanding at March 31, 2008                  |   |                  | 538,888   |   |                                 | $      | 0.62 |   |
|                                                        |   |                  |      |   |                                 |   |   |   |
| Options      exercisable at March 31, 2008                  |   |                  | 534,088   |   |                                 | $      | 0.72 |   |
| Weighted      average fair value of options granted in 2008 |   |                  |      |   |                                 |   | — |   |

----

----

----

----

----

----

| Number | Description      of Exhibit                                                                                                                       |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                              |
| 3.1    | Amended      and Restated Articles of Incorporation of Integrated Pharmaceuticals, Inc.      (1)                                                  |
|   |                                                                                                                                              |
| 3.2    | Amended      and Restated Bylaws of Integrated Pharmaceuticals, Inc.  (2)                                                                         |
|   |                                                                                                                                              |
| 4.1    | Specimen      Certificate for Integrated Pharmaceuticals, Inc. Common Stock, par value      $.01 per share (2)                                    |
|   |                                                                                                                                              |
| 4.2    | Form      of Common Stock Purchase Warrant (2)                                                                                                    |
|   |                                                                                                                                              |
| 10.1   | Amended      and Restated  Patent License Agreement with NEC Partners      (2)                                                          |
|   |                                                                                                                                              |
| 10.2   | Lease      Agreement with Chantilas Properties, LLC and Advanced Process      Technologies, Inc. (2)                                              |
|   |                                                                                                                                              |
| 10.3   | Assignment      and Assumption of Lease(2)                                                                                                        |
|   |                                                                                                                                              |
| 10.4   | Consulting      and Warrant Agreements with James Czirr (2)                                                                                       |
|   |                                                                                                                                              |
| 10.5   | 2002      Stock Plan (2)                                                                                                                          |
|   |                                                                                                                                              |
| 10.6   | Registration      Rights Agreement(2)                                                                                                             |
|   |                                                                                                                                              |
| 10.7   | Letter      dated May 5, 2005 amending the Patent License Agreement with NEC Partners      (3)                                                    |
|   |                                                                                                                                              |
| 10.8   | Letter      dated October 13, 2005 amending the Patent License Agreement with NEC      Partners (4)                                               |
|   |                                                                                                                                              |
| 10.9   | Investment      Agreement between the Company and Dutchess Private Equities Fund, LP dated      December 22, 2007 (5)                             |
|   |                                                                                                                                              |
| 10.10  | Registration      Rights Agreement between the Company and Dutchess Private Equities Fund,      LP dated December 22, 2007 (5)                    |
|   |                                                                                                                                              |
| 10.11  | Placement      Agent Agreement among the Company, US Euro Securities Inc. and Dutchess      Private Equities Fund, LP dated December 22, 2007 (5) |
|   |                                                                                                                                              |
| 14     | Financial      Code of Ethics (6)                                                                                                                 |
|   |                                                                                                                                              |
| 21     | Subsidiaries      of Integrated Pharmaceuticals (6)                                                                                               |

----

----